Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

1

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

174389329

Full Text :

https://doi.org/10.1200/JCO.23.02005